Rosetta Genomics (Rosetta Genomics) Short-Term Capital Lease Obligation : $0.06 Mil (As of Jun. 2017)

View and export this data going back to 2007. Start your Free Trial

What is Rosetta Genomics Short-Term Capital Lease Obligation?

Rosetta Genomics's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2017 was $0.06 Mil.

Rosetta Genomics's quarterly Short-Term Capital Lease Obligation stayed the same from Sep. 2016 ($0.06 Mil) to Dec. 2016 ($0.06 Mil) and stayed the same from Dec. 2016 ($0.06 Mil) to Jun. 2017 ($0.06 Mil).

Rosetta Genomics's annual Short-Term Capital Lease Obligation stayed the same from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.00 Mil) but then increased from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($0.06 Mil).

Rosetta Genomics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Rosetta Genomics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rosetta Genomics Short-Term Capital Lease Obligation Chart

Rosetta Genomics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.06

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	0.06	0.06	0.06

Rosetta Genomics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Rosetta Genomics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (OTCPK:ROSGQ) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Plaut Street, Science Park, Rehovot, ISR, 76706

Website

http://www.rosettagenomics.com

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Executives

Sabby Management, Llc	10 percent owner	115 HIDDEN HILLS DR, SPICEWOOD TX 78669
Sabby Healthcare Volatility Master Fund, Ltd.	10 percent owner	C/O SABBY MANAGEMENT, LLC, 10 MOUNTAINVIEW ROAD, SUITE 205, UPPER SADDLE RIVER NJ 07458

Rosetta Genomics (Rosetta Genomics) Headlines

From GuruFocus

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

By gurufocus • 12-09-2008